Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00355550 · ClinicalTrials.gov registry record · Phase 2
Tricaprilin In Age-Associated Memory Impairment
A Phase 2 study, sponsored by Cerecin.
- Completed
- Registry status
- Phase 2
- Development phase
- 156
- Enrollment target
NCT00355550: Completed Phase 2 study, sponsored by Cerecin.
NCT00355550 is a Phase 2 study that has completed, run by Cerecin. The registered enrollment target is 156 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00355550, a Phase 2 study, has completed, sponsored by Cerecin.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 156 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether tricaprilin, a compound that increases energy availability in the brain, improves memory in older adults with "normal" loss of memory abilities since early adult life.
Interventions
- OTHER Placebo
- DRUG Tricaprilin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 156 participants |
| Start Date | 2006-07 |
| Est. Completion | 2007-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00355550
The ClinicalTrials.gov registry entry for NCT00355550 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 156 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cerecin, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00355550 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00355550 about?
NCT00355550 is a clinical study titled "Tricaprilin In Age-Associated Memory Impairment". The purpose of this study is to determine whether tricaprilin, a compound that increases energy availability in the brain, improves memory in older adults with "normal" loss of memory abilities since early adult life.
What is the current status of trial NCT00355550?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 156 participants. The study started on 2006-07. Estimated completion is 2007-06.
What interventions are being tested in trial NCT00355550?
The interventions under investigation include: Placebo (OTHER), Tricaprilin (DRUG).
Who is sponsoring clinical trial NCT00355550?
This trial is sponsored by Cerecin, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.